Cullinan Associates’s Allergan Inc AGN Stock Holding History

Cullinan Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,000	Closed	-$354K	–	185
2020 Q1	$354K	Hold	2,000	–	–	0.03%	141
2019 Q4	$382K	Hold	2,000	–	–	0.03%	152
2019 Q3	$337K	Hold	2,000	–	–	0.02%	156
2019 Q2	$335K	Hold	2,000	–	–	0.02%	161
2019 Q1	$293K	Hold	2,000	–	–	0.02%	164
2018 Q4	$267K	Buy	+2,000	New	+$267K	0.02%	166
2014 Q3	–	Sell	-11,700	Closed	-$985K	–	99
2014 Q2	$985K	Buy	+11,700	New	+$1.82M	0.16%	69
2013 Q4	–	Sell	-14,000	Closed	-$1.27M	–	91
2013 Q3	$1.27M	Buy	14,000 +1,800	+15%	+$162K	0.17%	66
2013 Q2	$1.03M	Buy	+12,200	New	+$1.27M	0.14%	74

Cullinan Associates's AGN Position: Q2 2020 in Review

Cullinan Associates sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 2,000 shares — an estimated $354K sold.

Cullinan Associates first reported a position in AGN in Q2 2013 and held it in 9 quarters. The position peaked at $1.27M in Q3 2013. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Cullinan Associates reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
Cullinan Associates sold 2,000 Allergan Inc shares in Q2 2020, an estimated $354K.
Cullinan Associates first reported a position in Allergan Inc in Q2 2013 and held it in 9 quarters.
Cullinan Associates's Allergan Inc position peaked at $1.27M in Q3 2013.
0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.